Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19
Gang Ye, Ruangang Pan, Fan Bu, et al.
Journal of Virology (2023) Vol. 97, Iss. 11
Open Access | Times Cited: 11

Showing 11 citing articles:

Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years
Elena Alexander, Kam W. Leong
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
Yang Yang, Fang Li, Lanying Du
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
The Use of Heterologous Antigens for Biopanning Enables the Selection of Broadly Neutralizing Nanobodies Against SARS-CoV-2
V. S. Aripov, Anna V. Zaykovskaya, Ludmila V. Mechetina, et al.
Antibodies (2025) Vol. 14, Iss. 1, pp. 23-23
Open Access
Potent bivalent nanobody constructs that protect against the SARS-CoV-2 XBB variant
Peter Halfmann, Jeong Soo Lee, Nikki McArthur, et al.
npj Viruses (2025) Vol. 3, Iss. 1
Open Access
Dual-role epitope on SARS-CoV-2 spike enhances and neutralizes viral entry across different variants
Gang Ye, Fan Bu, Ruangang Pan, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 9, pp. e1012493-e1012493
Open Access | Times Cited: 3
Structure-guided in vitro evolution of nanobodies targeting new viral variants
Gang Ye, Fan Bu, Ruangang Pan, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 9, pp. e1012600-e1012600
Open Access | Times Cited: 3
Lys417 acts as a molecular switch that regulates the conformation of SARS-CoV-2 spike protein
Qibin Geng, Yushun Wan, Fu‐Chun Hsueh, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 6
Development of a broad-spectrum therapeutic Fc-nanobody for human noroviruses
Grant S. Hansman, Gargi Kher, Anna D. Svirina, et al.
Journal of Virology (2024) Vol. 98, Iss. 7
Closed Access | Times Cited: 1
Protein–protein and protein–nucleic acid binding site prediction via interpretable hierarchical geometric deep learning
Shizhuo Zhang, Jiyun Han, Juntao Liu
GigaScience (2024) Vol. 13
Open Access | Times Cited: 1
Discovery of Nanosota-9 as anti-Omicron nanobody therapeutic candidate
Gang Ye, Fan Bu, Divyasha Saxena, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 11, pp. e1012726-e1012726
Open Access | Times Cited: 1
Progress in the Development of Broadly Reactive Norovirus Therapeutics
Grant S. Hansman, Gargi Kher, Anna D. Svirina, et al.
Research Square (Research Square) (2024)
Open Access
Discovery of Nanosota-EB1 and -EB2 as Novel Nanobody Inhibitors Against Ebola Virus Infection
Fan Bu, Gang Ye, Kimberly M. Morsheimer, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 12, pp. e1012817-e1012817
Open Access
Page 1

Scroll to top